Erik Berntorp
About
In The Last Decade
Erik Berntorp
179 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Hematology 5.5k
- Genetics 1.4k
- Molecular Biology 653
- Cardiology and Cardiovascular Medicine 554
- Surgery 535
Countries citing papers authored by Erik Berntorp
This map shows the geographic impact of Erik Berntorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Berntorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Berntorp more than expected).
Fields of papers citing papers by Erik Berntorp
This network shows the impact of papers produced by Erik Berntorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Berntorp. The network helps show where Erik Berntorp may publish in the future.
Co-authorship network of co-authors of Erik Berntorp
This figure shows the co-authorship network connecting the top 25 collaborators of Erik Berntorp. A scholar is included among the top collaborators of Erik Berntorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Berntorp. Erik Berntorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 10 | |
| 4 | 1 | |
| 5 | Inhibitors in haemophilia A - Prevention, current management and personalised therapy perspectives | 1 |
| 6 | 11 | |
| 7 | Von Willebrand disease prophylaxis network | 1 |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 14 | |
| 11 | 18 | |
| 12 | Comparison of two prophylactic regimens for severe hemophilia: Intermediate dose versus high dose. | 1 |
| 13 | Immune tolerance induction and the treatment of hemophilia. Malmö protocol update. | 44 |
| 14 | Modern treatment of haemophilia. | 156 |
| 15 | [Resistance to activated protein C. A common genetic risk factor in venous thrombosis]. | 0 |
| 16 | 1 | |
| 17 | 88 | |
| 18 | 2 | |
| 19 | 59 | |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.